Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto, Haerani Rasyid, Anastasya Angelica Vicente, Winny Suciangto

Strategies to manage low-bone turnover Spasovski

Increased serum phosphate concentration within the normal reference levels is associated with all-cause mortality in non-dialysis CKD patients: A five-year prospective cohort study Ana Cerqueira, Janete Quelhas-Santos, Núria Paulo, Claúdia Camila Dias, Manuel Pestana